Key Events This Week
1 June: Stock opens at Rs.342.80, down 2.07% amid technical downgrade
2 June: Intraday high of Rs.366.75 with a 7.54% surge, despite downgrade to Strong Sell
3-5 June: Consolidation with minor fluctuations, closing the week at Rs.362.85 (-0.31% on final day)
Unichem Laboratories Ltd Gains 22.94%: 7 Key Factors Driving the Week’s Rally
2026-06-13 14:07:47
Key Events This Week
8 June: Stock opens at ₹357.15, down 1.57% amid broader market weakness
9 June: Mojo Grade upgraded to Sell from Strong Sell, stock closes at ₹378.05 (+5.85%)
10 June: Intraday high of ₹426 with a 13.46% surge, strong technical momentum
11 June: Exceptional volume surge, intraday high of ₹487, price up 10.61%
12 June: Technical momentum shifts to sideways trend, stock closes at ₹446.10 (-3.38%)

Unichem Laboratories Ltd Sees Technical Momentum Shift Amid Mixed Market Signals
2026-06-12 08:01:02Unichem Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key technical indicators. Despite a strong intraday rally pushing the stock price to ₹515.55, the broader monthly indicators suggest caution for investors navigating this small-cap pharmaceutical player.
Read full news article
Unichem Laboratories Ltd Valuation Shifts Amid Mixed Market Performance
2026-06-12 08:00:11Unichem Laboratories Ltd has experienced a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade, reflecting evolving market perceptions amid a challenging pharmaceutical sector landscape. Despite a recent 5.08% intraday gain, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now suggest a more tempered price attractiveness compared to its historical averages and peer group benchmarks.
Read full news article
Unichem Laboratories Ltd Sees Exceptional Volume Surge Amid Strong Price Rally
2026-06-11 11:00:08Unichem Laboratories Ltd (UNICHEMLAB), a small-cap player in the Pharmaceuticals & Biotechnology sector, witnessed extraordinary trading volumes on 11 Jun 2026, accompanied by a robust price rally. The stock surged 12.51% intraday, significantly outperforming its sector and the broader Sensex, signalling heightened investor interest and potential accumulation.
Read full news article
Unichem Laboratories Ltd Sees Surge in Value Trading Amid Strong Market Momentum
2026-06-11 10:00:09Unichem Laboratories Ltd witnessed a remarkable surge in trading activity on 11 June 2026, emerging as one of the most actively traded stocks by value in the Pharmaceuticals & Biotechnology sector. The stock outperformed its sector peers and broader market indices, buoyed by strong institutional participation and robust order flow, signalling renewed investor confidence despite a recent downgrade in its Mojo Grade.
Read full news article
Unichem Laboratories Ltd Surges 10.61% to Day's High of Rs 487 — Outperforms Sector by 10.04 Percentage Points
2026-06-11 09:51:21While the Sensex edged lower by 0.31%, Unichem Laboratories Ltd surged 10.61% on 11 Jun 2026, reaching an intraday high of Rs 487. This 10.04 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a market-wide lift.
Read full news article
Unichem Laboratories Ltd Surges 13.46% to Day's High of Rs 426 — Outperforms Sector by 10.55 Percentage Points
2026-06-10 10:32:07The Sensex rose modestly by 0.42% on 10 Jun 2026, but Unichem Laboratories Ltd surged 13.46%, outperforming its Pharmaceuticals & Biotechnology sector by 10.55 percentage points. This sharp single-session gain rewrites the short-term narrative for the small-cap stock, which has been on a volatile trajectory recently.
Read full news article
Unichem Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges
2026-06-09 08:38:23Unichem Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 8 June 2026, driven primarily by a shift in technical indicators despite ongoing financial headwinds. The pharmaceutical company’s Mojo Score improved to 34.0, reflecting a nuanced assessment across quality, valuation, financial trends, and technical parameters. This article analyses the key factors behind this rating change and what it means for investors navigating the small-cap pharmaceutical sector.
Read full news articleDisclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
12-Jun-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Equity Intelligence India Pvt Ltd
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
12-Jun-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Equity Intelligence India Pvt Ltd
Clarification sought from Unichem Laboratories Ltd
11-Jun-2026 | Source : BSEThe Exchange has sought clarification from Unichem Laboratories Ltd on June 11 2026 with reference to Movement in Volume.
The reply is awaited.
Corporate Actions
No Upcoming Board Meetings
Unichem Laboratories Ltd has declared 200% dividend, ex-date: 01 Aug 22
Unichem Laboratories Ltd has announced 2:5 stock split, ex-date: 21 Oct 10
No Bonus history available
No Rights history available






